NCT05129969 - Registry Platform Ovarian and Endometrial Cancer | Biotech Hunter

Enrollment

1,975

Participants

Timeline

Start Date

November 25, 2021

Primary Completion Date

December 31, 2030

Study Completion Date

December 31, 2030

Conditions

Ovarian CancerEndometrial CancerOvary NeoplasmEndometrial NeoplasmsCarcinoma, OvarianCarcinomaNeoplasm, Ovarian

Interventions

OTHER

Physician's choice according to patient's needs.

Routine care as per site standard.

Trial Locations (1)

RECRUITING

Multiple sites all over Germany, Multiple Locations

All Listed Sponsors

lead

iOMEDICO AG

INDUSTRY